Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-08 1:46 pm Sale | 2024-12-31 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 6,428,250 15.500% | -700,000 (-9.82%) | Filing History |
| 2025-01-08 1:38 pm Unchanged | 2024-12-31 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 14,666,600 17.470% | 0 (Unchanged) | Filing History |
| 2024-11-06 08:56 am Unchanged | 2024-10-31 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 7,128,250 17.220% | 0 (Unchanged) | Filing History |
| 2024-11-06 08:54 am Purchase | 2024-10-31 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | FEDERATED HERMES INC. FHI | 3,707,364 5.440% | 3,707,364 (New Position) | Filing History |
| 2024-10-07 1:38 pm Sale | 2024-09-30 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 7,128,250 18.830% | -966,450 (-11.94%) | Filing History |
| 2024-10-07 1:36 pm Purchase | 2024-09-30 | 13G | aTyr Pharma, Inc. ATYR | FEDERATED HERMES INC. FHI | 14,666,600 19.350% | 4,497,000 (+44.22%) | Filing History |
| 2024-10-07 1:33 pm Purchase | 2024-09-30 | 13G | Smith Douglas Homes Corp. SDHC | FEDERATED HERMES INC. FHI | 527,300 5.960% | 527,300 (New Position) | Filing History |
| 2024-09-09 11:31 am Sale | 2024-08-31 | 13G | Dynavax Technologies Corporation DVAX | FEDERATED HERMES INC. FHI | 6,158,200 4.700% | -5,206,466 (-45.81%) | Filing History |
| 2024-06-07 1:30 pm Purchase | 2024-05-31 | 13G | Federated Hermes, Inc. FHI | BlackRock Inc. BLK | 8,559,207 10.200% | 448,444 (+5.53%) | Filing History |
| 2024-04-08 09:10 am Sale | 2024-03-31 | 13G | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 95,000 0.110% | -10,621,153 (-99.11%) | Filing History |
| 2024-03-25 5:29 pm Sale | 2024-03-18 | 13D | Fusion Pharmaceuticals Inc. FUSN | FEDERATED HERMES INC. FHI | 10,716,153 12.650% | -170,000 (-1.56%) | Filing History |
| 2024-03-11 09:59 am Purchase | 2024-02-29 | 13G | Federated Hermes, Inc. FHI | VANGUARD GROUP INC | 8,690,618 10.290% | 158,153 (+1.85%) | Filing History |
| 2024-03-06 10:25 am Sale | 2024-02-29 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 2,297,700 3.980% | -1,339,609 (-36.83%) | Filing History |
| 2024-03-06 10:23 am Sale | 2024-02-29 | 13G | Amphastar Pharmaceuticals, Inc. AMPH | FEDERATED HERMES INC. FHI | 2,165,071 4.520% | -1,107,690 (-33.85%) | Filing History |
| 2024-02-13 5:04 pm Sale | 2023-12-29 | 13G | Federated Hermes, Inc. FHI | VANGUARD GROUP INC | 8,532,465 9.890% | -181,067 (-2.08%) | Filing History |
| 2024-02-09 09:03 am Purchase | 2024-02-08 | 13G | Federated Hermes, Inc. FHI | FMR LLC | 5,593,701 6.485% | 5,592,089 (+346903.78%) | Filing History |
| 2024-02-07 08:20 am Sale | 2024-01-31 | 13G | P10, Inc. PX | FEDERATED HERMES INC. FHI | 2,600,000 4.890% | -581,933 (-18.29%) | Filing History |
| 2024-01-25 1:48 pm Purchase | 2023-12-31 | 13G | Federated Hermes, Inc. FHI | BlackRock Inc. BLK | 8,110,763 9.400% | 197,325 (+2.49%) | Filing History |
| 2024-01-18 10:32 am Sale | 2023-12-31 | 13G | ShotSpotter, Inc. SSTI | FEDERATED HERMES INC. FHI | 1,315,000 10.340% | -5,594 (-0.42%) | Filing History |
| 2024-01-18 10:31 am Purchase | 2023-12-31 | 13G | SCYNEXIS, Inc. SCYX | FEDERATED HERMES INC. FHI | 8,094,700 19.990% | 1,227,786 (+17.88%) | Filing History |